Clinical Trials Directory

Trials / Completed

CompletedNCT02900287

Cancer Survival in Reunion Island , 1998-2008 (SUCRE)

Survie Des Personnes Atteintes de Cancer à la Réunion, 1998-2008 (SUCRE)

Status
Completed
Phase
Study type
Observational
Enrollment
18,000 (actual)
Sponsor
Centre Hospitalier Universitaire de la Réunion · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

Cancer survival is important to determine prognostic of patients and evaluate care and prevention health strategies. Sucre is the first study to describe cancer survival in Reunion Island. Sucre aims at evaluating five year cancer prognostic in Reunion Island by cancer site and gender. Sucre is a retrospective cohort study of cancer diagnosed between 01/01/1998 and 31/12/2008.

Detailed description

Data are extracted from Reunion Island Cancer Registry.

Conditions

Timeline

Start date
2019-01-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2016-09-14
Last updated
2024-01-05

Locations

1 site across 1 country: Reunion

Source: ClinicalTrials.gov record NCT02900287. Inclusion in this directory is not an endorsement.

Cancer Survival in Reunion Island , 1998-2008 (SUCRE) (NCT02900287) · Clinical Trials Directory